-
公开(公告)号:US12110327B2
公开(公告)日:2024-10-08
申请号:US17931757
申请日:2022-09-13
Applicant: Alector LLC
Inventor: Andrew Pincetic , Arnon Rosenthal , Helen Lam , Francesca Avogadri-Connors , Seung-Joo Lee
IPC: C07K16/28
CPC classification number: C07K16/2803 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/73 , C07K2317/75 , C07K2317/76 , C07K2317/77 , C07K2317/80 , C07K2317/92
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM1 protein, e.g., a mammalian TREM1 or human TREM1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US12258398B2
公开(公告)日:2025-03-25
申请号:US17263534
申请日:2019-07-26
Applicant: Alector LLC
Inventor: Patricia Culp , Rashmi Bankoti , Helen Lam , Arnon Rosenthal
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a Siglec-5 protein, e.g., human Siglec-5, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US10590198B2
公开(公告)日:2020-03-17
申请号:US15756043
申请日:2016-08-26
Applicant: Alector LLC
Inventor: Kate Monroe , Helen Lam , Arnon Rosenthal , Seung-Joo Lee , Francesca Avogadri-Connors , William Monteith
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20190315858A1
公开(公告)日:2019-10-17
申请号:US16382117
申请日:2019-04-11
Applicant: ALECTOR LLC
Inventor: Kate Monroe , Tina Schwabe , Francesca Avogadri-Connors , Ilaria Tassi , Helen Lam , Arnon Rosenthal
IPC: C07K16/28
Abstract: The invention is generally directed to methods and compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM2 protein, e.g., a mammalian TREM2 and/or human TREM2. The methods provided herein find use in preventing, reducing risk, or treating an individual having dementia, frontotemporal dementia, Alzheimer's disease, Nasu-Hakola disease, or multiple sclerosis.
-
公开(公告)号:US11965023B2
公开(公告)日:2024-04-23
申请号:US17740100
申请日:2022-05-09
Applicant: Alector LLC
Inventor: Kate Monroe , Helen Lam , Patricia Culp , Arnon Rosenthal
IPC: C07K16/28 , A61K39/00 , A61P25/00 , A61P25/08 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P37/00
CPC classification number: C07K16/2803 , A61P25/00 , A61P25/08 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P37/00 , A61K2039/505 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Siglec-5 protein, e.g., human Siglec-5 or a mammalian Siglec-5, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US11472877B2
公开(公告)日:2022-10-18
申请号:US16078965
申请日:2017-03-03
Applicant: Alector LLC
Inventor: Andrew Pincetic , Arnon Rosenthal , Helen Lam , Francesca Avogadri-Connors , Seung-Joo Lee
IPC: C07K16/28
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM1 protein, e.g., a mammalian TREM1 or human TREM1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US11359014B2
公开(公告)日:2022-06-14
申请号:US16614302
申请日:2018-05-15
Applicant: Alector LLC
Inventor: Kate Monroe , Helen Lam , Patricia Culp , Arnon Rosenthal
IPC: C07K16/28 , A61P37/00 , A61P25/28 , A61P31/04 , A61P25/00 , A61P25/08 , A61P29/00 , A61P35/00 , A61K39/00
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Siglec-5 protein, e.g., human Siglec-5 or a mammalian Siglec-5, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20250092131A1
公开(公告)日:2025-03-20
申请号:US18824619
申请日:2024-09-04
Applicant: Alector LLC
Inventor: Andrew Pincetic , Arnon Rosenthal , Helen Lam , Francesca Avogadri-Connors , Seung-Joo Lee
IPC: C07K16/28
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM1 protein, e.g., a mammalian TREM1 or human TREM1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US12227568B2
公开(公告)日:2025-02-18
申请号:US16972840
申请日:2019-06-07
Applicant: Alector LLC
Inventor: Patricia Culp , Seung-Joo Lee , Helen Lam , Wei-Hsien Ho , Arnon Rosenthal
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US11254743B2
公开(公告)日:2022-02-22
申请号:US16869315
申请日:2020-05-07
Applicant: ALECTOR LLC
Inventor: Patricia Culp , Helen Lam , Arnon Rosenthal , Seung-Joo Lee , Nels P. Nielson , Robert Pejchal
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
-
-
-
-
-
-
-
-